NIH: Clinical Trial to Test Immune Modulation Strategy for Hospitalized COVID-19 Patients Begins
September 23, 2023
September 23, 2023
WASHINGTON, Sept. 23 -- The U.S. Department of Health and Human Services' National Institutes of Health issued the following news release on Sept. 22, 2023:
* * *
Part of NIH's STRIVE consortium, the therapeutic may prevent overactive immune systems from causing severe symptoms.
* * *
A clinical trial has launched to test whether early intensive immune modulation for hospitalized COVID-19 patients with relatively mild illness is benef . . .
* * *
Part of NIH's STRIVE consortium, the therapeutic may prevent overactive immune systems from causing severe symptoms.
* * *
A clinical trial has launched to test whether early intensive immune modulation for hospitalized COVID-19 patients with relatively mild illness is benef . . .